SEC Form 4/A · accession 0001437749-16-033159
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Nicholas Tompkins
Director
Period of report
May 26, 2016
Accepted (ET)
Jun 1, 2016 · 2:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Right to Buy Restricted Stock Unit (RSU)F5,F1,F4 | — | May 25, 2016 | M | 2,201 | A | Oct 25, 2016 | — | Common Stock | 2,201 | 2,201 | I |
Explanation of responses
- F1The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
- F4Restricted Stock Units will vest 5 months from the grant date and will be automatically settled in shares of common stock.
- F5The proper transaction date for this grant is May 25, 2016 versus May 26, 2016. Therefore, the amount granted becomes 2,201 versus 2,167.